MARKET

RGNX

RGNX

Regenxbio
NASDAQ
16.46
-1.22
-6.90%
After Hours: 16.46 0 0.00% 18:06 09/29 EDT
OPEN
17.74
PREV CLOSE
17.68
HIGH
17.84
LOW
16.14
VOLUME
613.93K
TURNOVER
0
52 WEEK HIGH
27.20
52 WEEK LOW
16.14
MARKET CAP
723.60M
P/E (TTM)
-2.6047
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at RGNX last week (0918-0922)?
Weekly Report · 5d ago
Orchard Therapeutics: A Reassessment
Seeking Alpha · 09/18 13:20
Weekly Report: what happened at RGNX last week (0911-0915)?
Weekly Report · 09/18 09:27
Weekly Report: what happened at RGNX last week (0904-0908)?
Weekly Report · 09/11 09:27
Weekly Report: what happened at RGNX last week (0828-0901)?
Weekly Report · 09/04 12:32
Regenxbio: Current report
Press release · 09/01 21:08
Regenxbio: Prospectus [Rule 424(b)(5)]
Press release · 09/01 21:08
Morgan Stanley Maintains Regenxbio (RGNX) Overweight Recommendation
NASDAQ · 08/29 22:13
More
About RGNX
REGENXBIO Inc. is a clinical-stage biotechnology company, which is focused on providing curative potential of gene therapy. Its investigational gene therapies are designed to deliver functional genes to address genetic defects in cells. The Company’s investigational AAV Therapeutics include RGX-314, RGX-202, RGX-121, RGX-111 and RGX-181 and RGX-381. RGX-314 is meant for the treatment of large patient populations impacted by wet age-related macular degeneration (wet AMD), diabetic retinopathy and other chronic retinal diseases. RGX-202 is developed to treat Duchenne muscular dystrophy, one of the common fatal genetic disorders affecting children. RGX-121, RGX-111 and RGX-181 are developed to treat Mucopolysaccharidosis type II, Mucopolysaccharidosis type I, and late infantile neuronal ceroid lipofuscinosis type II (CLN2 disease), all of which are progressive, neurodegenerative lysosomal storage disorders. RGX-381 is developed to treat the ocular manifestations of CLN2 disease.

Webull offers kinds of Regenxbio Inc stock information, including NASDAQ:RGNX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RGNX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading RGNX stock methods without spending real money on the virtual paper trading platform.